Fred M. Powell

Insider Reports History

Location
Plymouth Meeting, PA
Signature
/s/ Amy Garabedian, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fred M. Powell:

Company Role Class Num Shares Value Price $ Report Date Ownership
LAVA Therapeutics NV Chief Financial Officer Common Shares 0 $0 $1.63 13 Nov 2025 Direct
ANTARES PHARMA, INC. Executive Vice President & CFO Common Stock 0 $5.60 24 May 2022 Direct
ANTARES PHARMA, INC. Executive Vice President & CFO Stock Option (right to buy) 0 24 May 2022 Direct
LAVA Therapeutics NV Chief Financial Officer Share Options (Right to Buy) 0 13 Nov 2025 Direct

Insider Reports Filed by Fred M. Powell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LVTX LAVA Therapeutics NV 13 Nov 2025 2 $0 4 Chief Financial Officer 17 Nov 2025, 16:30
LVTX LAVA Therapeutics NV 13 Feb 2025 1 $0 4 Chief Financial Officer 18 Feb 2025, 20:15
LVTX LAVA Therapeutics NV 01 Jan 2025 0 $0 3 Chief Financial Officer 02 Jan 2025, 09:20
ATRS ANTARES PHARMA, INC. 24 May 2022 9 -$5,125,512 4 Executive Vice President & CFO 26 May 2022, 17:24
ATRS ANTARES PHARMA, INC. 03 Mar 2022 2 -$43,723 4 Executive Vice President & CFO 04 Mar 2022, 17:36
ATRS ANTARES PHARMA, INC. 16 Feb 2022 2 -$42,075 4 Executive Vice President & CFO 18 Feb 2022, 18:16
ATRS ANTARES PHARMA, INC. 10 Jun 2021 4 +$250,030 4 Executive Vice President & CFO 14 Jun 2021, 18:24
ATRS ANTARES PHARMA, INC. 08 Jun 2021 1 -$52,878 4 Executive Vice President & CFO 10 Jun 2021, 17:39